儿童黑色素瘤:系统综述与个体患者Meta分析
该系统综述检索1948年至2021年1月25日文献,纳入报告≤18岁皮肤黑色素瘤患者的研究,最终从213项研究提取1002例患者数据进行个体患者Meta分析。结果显示结节性黑色素瘤的黑色素瘤特异性生存低于浅表扩散性和Spitz样黑色素瘤,Spitz样黑色素瘤进展风险显著高于浅表扩散性但死亡率趋势更低。
要点
- 结节性黑色素瘤的黑色素瘤特异性生存低于浅表扩散性和Spitz样黑色素瘤。
- Spitz样黑色素瘤进展风险显著高于浅表扩散性,但死亡率趋势更低。
- Spitz样黑色素瘤行为介于浅表扩散性和结节性之间,提出儿童Spitz样病变是否被过度诊断为黑色素瘤的问题。
核心结论
- 儿童黑色素瘤存在不同生物学模式,Spitz样黑色素瘤行为介于浅表扩散性和结节性之间,表现为淋巴结进展风险高但死亡率低。
- 作者提出儿童Spitz样病变是否被过度诊断为黑色素瘤的问题。
研究设计与样本
- 系统综述,检索1948年至2021年1月25日文献,纳入报告至少1例≤18岁皮肤黑色素瘤患者的研究,排除原发灶不明和恶性不确定的黑色素瘤。
- 三对作者独立进行标题/摘要筛选,两位不同作者审阅相关全文,定性合成时手工交叉核对重叠数据,随后提取个体患者数据进行患者水平Meta分析。
- 定性合成覆盖266项研究,个体患者数据来自213项研究共1002例患者。
- PROSPERO注册号:CRD42021233248。
主要发现
- 结节性黑色素瘤的黑色素瘤特异性生存低于浅表扩散性和Spitz样黑色素瘤,无进展生存低于浅表扩散性。
- Spitz样黑色素瘤进展风险显著高于浅表扩散性,死亡率趋势更低。
- 新生黑色素瘤进展后黑色素瘤特异性生存优于先天性痣相关黑色素瘤,无进展生存无差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The current evidence on paediatric melanoma is heterogeneous, especially regarding the prognosis of different histological subtypes. We sought to systematically review the evidence on paediatric melanoma, highlighting the major sources of heterogeneity and focusing on available data on single patients. A systematic search was performed from 1948 to 25 January 2021. Only studies reporting at least one case of cutaneous melanoma in patients aged ≤18 years were included. Unknown primary and uncertain malignant melanomas were excluded. Three couples of authors independently performed title/abstract screening and two different authors reviewed all the relevant full texts. The selected articles were manually cross-checked for overlapping data for qualitative synthesis. Subsequently data on single patients were extracted to perform a patient-level meta-analysis. PROSPERO registration number: CRD42021233248. The main outcomes were melanoma-specific survival (MSS) and progression-free survival (PFS) outcomes. Separate analyses were done of cases with complete information on histologic subtype, focusing on superficial spreading (SSM), nodular (NM) and spitzoid melanomas, as well as of those classified as de-novo (DNM) and acquired or congenital nevus-associated melanomas (NAM). The qualitative synthesis covered 266 studies; however, data on single patients were available from 213 studies including 1002 patients. Among histologic subtypes, NM had a lower MSS than both SSM and spitzoid melanoma, and a lower PFS than SSM. Spitzoid melanoma had a significantly higher progression risk than SSM and trended toward lower mortality. Focusing on nevus-associated status, DNM demonstrated better MSS after progression than congenital NAM, and no differences were highlighted in PFS. Our findings describe the existence of different biological patterns in paediatric melanoma. Specifically, spitzoid melanomas demonstrated intermediate behaviour between SSM and NM and showed a high risk of nodal progression but low mortality. This raises the question of whether spitzoid lesions are being over-diagnosed as melanoma in childhood.
引用
- Pampena R, Piccolo V, Muscianese M, et al. Melanoma in children: A systematic review and individual patient meta-analysis. J Eur Acad Dermatol Venereol. 2023. PMID: 37210654. doi:10.1111/jdv.19220
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。